Literature DB >> 26842064

Glioblastoma in long-term survivors of acute lymphoblastic leukemia: Report of two cases.

Zi Wang1,2, Yuzo Terakawa1, Hiroyuki Goto1, Naohiro Tsuyuguchi1, Hidetoshi Sato1, Junya Abe1, Kenji Ohata1.   

Abstract

Acute lymphoblastic leukemia (ALL) is the most common form of cancer in children. Second neoplasms as late effects of therapy for ALL have been recognized as a significant clinical issue given the increasing number of long-term survivors of ALL, because they can be the cause of death in such cases. In contrast, glioblastoma (GBM) is the most common primary brain tumor in adults. It is a malignant brain tumor that most often occurs in elderly patients, and GBM in young adults or adolescents appears to be rare. Here, we describe our experience of two cases of GBM in young long-term survivors of ALL, and emphasize the necessity of careful follow up of patients treated for ALL for the potential occurrence of central nervous system second neoplasms, especially when the patients have previously undergone cranial radiotherapy.
© 2016 Japan Pediatric Society.

Entities:  

Keywords:  acute lymphoblastic leukemia; glioblastoma; late effect; second neoplasm

Year:  2016        PMID: 26842064     DOI: 10.1111/ped.12843

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  2 in total

Review 1.  Advances in immunotherapeutic research for glioma therapy.

Authors:  Jeremy Tetsuo Miyauchi; Stella E Tsirka
Journal:  J Neurol       Date:  2017-12-05       Impact factor: 4.849

2.  ANO6 promotes cell proliferation and invasion in glioma through regulating the ERK signaling pathway.

Authors:  Zhao-Bo Xuan; Ye-Ji Wang; Jun Xie
Journal:  Onco Targets Ther       Date:  2019-08-20       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.